Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Esserman

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
Msystems|October 29, 2024
Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma <i>in situ</i>, and healthy womenEmma McCune, Anukriti Sharma, Breanna Johnson, et al.
Research Square|January 23, 2024
Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centersThomas O'Keefe, Christina Yau, Emma Iaconetti, et al.
Breast Cancer Research and Treatment|July 17, 2012
The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivorsMeredith Bock, Dan Moore, Jimmy Hwang, et al.
Breast Cancer Research : BCR|November 1, 2013
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic riskChristina Yau, John Sninsky, Shirley Kwok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2024
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast CancerAlejandro Ríos-Hoyo, Erin Cobain, Laura A Huppert, et al.
International Journal of Cancer|December 6, 2008
Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patientsDejana Braithwaite, C Martin Tammemagi, Dan H Moore, et al.
The Breast Journal|September 22, 2005
Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancerYah-Yuen Tan, Chen-Teng Wu, Yang-Guo Fan, et al.
JAMA|October 20, 2005
Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestryRita Nanda, L Philip Schumm, Shelly Cummings, et al.
JMIR Cancer|December 2, 2024
Relationship Between Perceived COVID-19 Risk and Change in Perceived Breast Cancer Risk: Prospective Observational StudyRyan Baxter-King, Arash Naeim, Tina Q Huang, et al.
Nature Communications|November 6, 2021
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancerOlav Engebraaten, Christina Yau, Kristian Berg, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Msystems|October 29, 2024
Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma <i>in situ</i>, and healthy womenEmma McCune, Anukriti Sharma, Breanna Johnson, et al.
Research Square|January 23, 2024
Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centersThomas O'Keefe, Christina Yau, Emma Iaconetti, et al.
Breast Cancer Research and Treatment|July 17, 2012
The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivorsMeredith Bock, Dan Moore, Jimmy Hwang, et al.
Breast Cancer Research : BCR|November 1, 2013
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic riskChristina Yau, John Sninsky, Shirley Kwok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2024
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast CancerAlejandro Ríos-Hoyo, Erin Cobain, Laura A Huppert, et al.
International Journal of Cancer|December 6, 2008
Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patientsDejana Braithwaite, C Martin Tammemagi, Dan H Moore, et al.
The Breast Journal|September 22, 2005
Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancerYah-Yuen Tan, Chen-Teng Wu, Yang-Guo Fan, et al.
JAMA|October 20, 2005
Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestryRita Nanda, L Philip Schumm, Shelly Cummings, et al.
JMIR Cancer|December 2, 2024
Relationship Between Perceived COVID-19 Risk and Change in Perceived Breast Cancer Risk: Prospective Observational StudyRyan Baxter-King, Arash Naeim, Tina Q Huang, et al.
Nature Communications|November 6, 2021
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancerOlav Engebraaten, Christina Yau, Kristian Berg, et al.
Pageof 15